Baqai, Junaid
Baqai, Junaid was paid $493K by Medicaid between Jan 2018 and Nov 2024, across 57 billing codes. Its largest line is 87502, Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets — 18% of everything it billed.
33Billing provider infoBAQAI, JUNAID
SPRINGFIELD, IL 62781
SPRINGFIELD, IL 62781
33aNPI1093989212assigned 04/18/2008
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$493K
24GClaims57,717
24DCodes billed57
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in Illinois
Rank by total paid#45 of 981
Median peer was paid$27K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,293 | $34K | |
| 2019 | 11,711 | $80K | |
| 2020 | 10,270 | $77K | |
| 2021 | 5,870 | $59K | |
| 2022 | 9,546 | $103K | |
| 2023 | 4,250 | $48K | |
| 2024incomplete | 10,777 | $90K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 18% | 2,424 | 2,199 | $86K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12% | 1,769 | 1,614 | $61K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12% | 1,627 | 1,388 | $61K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10% | 10,509 | 8,172 | $52K |
| 80053 | Comprehensive metabolic panel | 10% | 9,860 | 7,983 | $50K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.3% | 996 | 864 | $26K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.2% | 1,867 | 1,738 | $16K |
| 84484 | 2.2% | 2,648 | 2,111 | $11K | |
| 87088 | 2.1% | 1,919 | 1,676 | $10K | |
| 83690 | 1.9% | 2,749 | 2,402 | $9K | |
| 85060 | 1.7% | 660 | 602 | $8K | |
| 88307 | 1.6% | 95 | 93 | $8K |
45 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 96 | $8K |
| 81001 | 1.5% | 5,461 | $7K | |
| 84703 | 1.4% | 2,023 | $7K | |
| 83605 | 1.3% | 1,450 | $7K | |
| 87040 | 1.3% | 607 | $7K | |
| 83735 | 1.3% | 1,950 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.3% | 281 | $6K |
| 83880 | 1.3% | 646 | $6K | |
| 82803 | <1% | 597 | $4K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 191 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 413 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 161 | $3K |
| 87186 | <1% | 511 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 589 | $2K |
| 85610 | <1% | 1,240 | $2K | |
| 88342 | <1% | 116 | $2K | |
| 88189 | <1% | 35 | $2K | |
| 86141 | <1% | 224 | $2K | |
| 80061 | Lipid panel | <1% | 371 | $1K |
| 85378 | <1% | 395 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 54 | $1K |
| 85730 | <1% | 407 | $1K | |
| 80305 | <1% | 398 | $1K | |
| 82150 | <1% | 311 | $998.47 | |
| 88304 | <1% | 30 | $665.15 | |
| 88341 | <1% | 13 | $641.95 | |
| 87070 | <1% | 231 | $641.70 | |
| 86140 | <1% | 209 | $488.80 | |
| 84702 | <1% | 99 | $454.71 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 99 | $318.85 |
| 82962 | <1% | 207 | $267.77 | |
| 84165 | <1% | 72 | $267.75 | |
| 83020 | <1% | 54 | $228.43 | |
| 85652 | <1% | 195 | $226.63 | |
| 85027 | <1% | 309 | $175.07 | |
| 86615 | <1% | 28 | $166.60 | |
| 85007 | <1% | 279 | $157.50 | |
| 86334 | <1% | 13 | $128.87 | |
| 82607 | <1% | 17 | $111.60 | |
| 82550 | <1% | 50 | $100.32 | |
| 88311 | <1% | 14 | $55.81 | |
| 84439 | <1% | 13 | $53.16 | |
| 82247 | <1% | 21 | $51.26 | |
| 80050 | General health panel | <1% | 26 | $21.30 |
| 84145 | 0% | 88 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.